PMC:7253482 / 6162-6381 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"278","span":{"begin":174,"end":186},"obj":"Chemical"},{"id":"279","span":{"begin":192,"end":199},"obj":"Chemical"},{"id":"295","span":{"begin":70,"end":87},"obj":"Disease"},{"id":"296","span":{"begin":120,"end":124},"obj":"Disease"},{"id":"297","span":{"begin":132,"end":136},"obj":"Disease"}],"attributes":[{"id":"A279","pred":"tao:has_database_id","subj":"279","obj":"MESH:D011134"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"MESH:D000848"},{"id":"A296","pred":"tao:has_database_id","subj":"296","obj":"MESH:D045169"},{"id":"A297","pred":"tao:has_database_id","subj":"297","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":120,"end":124},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T39","span":{"begin":106,"end":107},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":192,"end":199},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T929","span":{"begin":19,"end":25},"obj":"NN"},{"id":"T930","span":{"begin":26,"end":40},"obj":"NN"},{"id":"T931","span":{"begin":41,"end":42},"obj":"-LRB-"},{"id":"T932","span":{"begin":42,"end":52},"obj":"NN"},{"id":"T933","span":{"begin":52,"end":53},"obj":"-RRB-"},{"id":"T934","span":{"begin":55,"end":64},"obj":"NN"},{"id":"T935","span":{"begin":65,"end":69},"obj":"IN"},{"id":"T936","span":{"begin":70,"end":85},"obj":"NN"},{"id":"T937","span":{"begin":86,"end":87},"obj":"NN"},{"id":"T938","span":{"begin":88,"end":89},"obj":"-LRB-"},{"id":"T939","span":{"begin":89,"end":93},"obj":"NNP"},{"id":"T940","span":{"begin":94,"end":95},"obj":"NN"},{"id":"T941","span":{"begin":95,"end":96},"obj":"-RRB-"},{"id":"T942","span":{"begin":97,"end":105},"obj":"VBD"},{"id":"T943","span":{"begin":106,"end":107},"obj":"DT"},{"id":"T944","span":{"begin":108,"end":118},"obj":"NN"},{"id":"T945","span":{"begin":119,"end":120},"obj":"-LRB-"},{"id":"T946","span":{"begin":120,"end":124},"obj":"NN"},{"id":"T947","span":{"begin":125,"end":129},"obj":"CD"},{"id":"T948","span":{"begin":129,"end":130},"obj":"NN"},{"id":"T949","span":{"begin":130,"end":131},"obj":"-SEMICOLON-"},{"id":"T950","span":{"begin":132,"end":136},"obj":"NNS"},{"id":"T951","span":{"begin":137,"end":141},"obj":"CD"},{"id":"T952","span":{"begin":141,"end":142},"obj":"NN"},{"id":"T953","span":{"begin":142,"end":143},"obj":"-COMMA-"},{"id":"T954","span":{"begin":144,"end":148},"obj":"NN"},{"id":"T955","span":{"begin":149,"end":153},"obj":"CD"},{"id":"T956","span":{"begin":153,"end":154},"obj":"NN"},{"id":"T957","span":{"begin":154,"end":155},"obj":"-RRB-"},{"id":"T958","span":{"begin":156,"end":158},"obj":"IN"},{"id":"T959","span":{"begin":159,"end":173},"obj":"VBN"},{"id":"T960","span":{"begin":174,"end":191},"obj":"JJ"},{"id":"T961","span":{"begin":192,"end":199},"obj":"NNS"},{"id":"T962","span":{"begin":200,"end":201},"obj":"-LRB-"},{"id":"T963","span":{"begin":201,"end":208},"obj":"NN"},{"id":"T964","span":{"begin":208,"end":209},"obj":"-RRB-"},{"id":"T965","span":{"begin":211,"end":215},"obj":"DT"}],"relations":[{"id":"R934","pred":"arg1Of","subj":"T930","obj":"T929"},{"id":"R935","pred":"arg1Of","subj":"T930","obj":"T931"},{"id":"R936","pred":"arg2Of","subj":"T932","obj":"T931"},{"id":"R937","pred":"arg3Of","subj":"T933","obj":"T931"},{"id":"R938","pred":"arg1Of","subj":"T934","obj":"T935"},{"id":"R939","pred":"arg2Of","subj":"T937","obj":"T935"},{"id":"R940","pred":"arg1Of","subj":"T937","obj":"T936"},{"id":"R941","pred":"arg1Of","subj":"T937","obj":"T938"},{"id":"R942","pred":"arg2Of","subj":"T940","obj":"T938"},{"id":"R943","pred":"arg3Of","subj":"T941","obj":"T938"},{"id":"R944","pred":"arg1Of","subj":"T940","obj":"T939"},{"id":"R945","pred":"arg1Of","subj":"T934","obj":"T942"},{"id":"R946","pred":"arg2Of","subj":"T944","obj":"T942"},{"id":"R947","pred":"arg1Of","subj":"T944","obj":"T943"},{"id":"R948","pred":"arg1Of","subj":"T944","obj":"T945"},{"id":"R949","pred":"arg2Of","subj":"T948","obj":"T945"},{"id":"R950","pred":"arg3Of","subj":"T957","obj":"T945"},{"id":"R951","pred":"arg1Of","subj":"T948","obj":"T946"},{"id":"R952","pred":"arg1Of","subj":"T948","obj":"T947"},{"id":"R953","pred":"arg1Of","subj":"T948","obj":"T949"},{"id":"R954","pred":"arg2Of","subj":"T952","obj":"T949"},{"id":"R955","pred":"arg1Of","subj":"T952","obj":"T950"},{"id":"R956","pred":"arg1Of","subj":"T952","obj":"T951"},{"id":"R957","pred":"arg1Of","subj":"T948","obj":"T953"},{"id":"R958","pred":"arg2Of","subj":"T956","obj":"T953"},{"id":"R959","pred":"arg1Of","subj":"T956","obj":"T954"},{"id":"R960","pred":"arg1Of","subj":"T956","obj":"T955"},{"id":"R961","pred":"arg1Of","subj":"T944","obj":"T958"},{"id":"R962","pred":"arg2Of","subj":"T961","obj":"T958"},{"id":"R963","pred":"arg2Of","subj":"T961","obj":"T959"},{"id":"R964","pred":"arg1Of","subj":"T961","obj":"T960"},{"id":"R965","pred":"arg1Of","subj":"T961","obj":"T962"},{"id":"R966","pred":"arg2Of","subj":"T963","obj":"T962"},{"id":"R967","pred":"arg3Of","subj":"T964","obj":"T962"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-CHEBI

    {"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T45","span":{"begin":192,"end":199},"obj":"Chemical"}],"attributes":[{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T46","span":{"begin":120,"end":124},"obj":"Species"},{"id":"T47","span":{"begin":132,"end":136},"obj":"Species"}],"attributes":[{"id":"A46","pred":"ncbi_taxonomy_id","subj":"T46","obj":"NCBItxid:694009"},{"id":"A47","pred":"ncbi_taxonomy_id","subj":"T47","obj":"NCBItxid:1335626"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T36","span":{"begin":55,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T26","span":{"begin":120,"end":124},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"295","span":{"begin":70,"end":87},"obj":"Disease"},{"id":"296","span":{"begin":120,"end":124},"obj":"Disease"},{"id":"297","span":{"begin":132,"end":136},"obj":"Disease"},{"id":"278","span":{"begin":174,"end":186},"obj":"Chemical"},{"id":"279","span":{"begin":192,"end":199},"obj":"Chemical"}],"attributes":[{"id":"A295","pred":"pubann:denotes","subj":"295","obj":"MESH:D000848"},{"id":"A296","pred":"pubann:denotes","subj":"296","obj":"MESH:D045169"},{"id":"A297","pred":"pubann:denotes","subj":"297","obj":"MESH:D018352"},{"id":"A279","pred":"pubann:denotes","subj":"279","obj":"MESH:D011134"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T36","span":{"begin":55,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"-ultra-performance liquid chromatography (HILIC-UPLC). Treatment with endoglycosidase H (Endo H) revealed a population (SARS 32.2%; MERS 33.8%, HKU1 25.0%) of underprocessed oligomannose-type glycans (Fig. 1b). This obs"}